Patents by Inventor Christopher RABENDER

Christopher RABENDER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATING COVID-19 WITH SEPIAPTERIN
    Publication number: 20240122931
    Abstract: The invention features methods of treating a SARS-CoV-2 infection in a subject, the method comprising administering to the subject an effective amount of sepiapterin or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: February 9, 2022
    Publication date: April 18, 2024
    Inventors: Gene Chatman CLARK, Eleonora MEZZAROMA, Christopher RABENDER, Ross B. MIKKELSEN, Vasily YAKOVLEV, Neil SMITH
  • METHODS FOR TREATING GLIOBLASTOMAS WITH SEPIAPTERIN
    Publication number: 20240115572
    Abstract: The invention features methods of treating glioblastoma in a subject, the method comprising administering to the subject an effective amount of sepiapterin or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: February 9, 2022
    Publication date: April 11, 2024
    Inventors: Christopher RABENDER, Gene Chatman CLARK, Eleonora MEZZAROMA, Ross B. MIKKELSEN, Vasily YAKOVLEV, Neil SMITH
  • USE OF SEPIAPTERIN AND METABOLITES THEREOF TO TREAT RADIATION EXPOSURE
    Publication number: 20220273661
    Abstract: The invention provides methods for treating radiation exposure in a subject by administering sepiapterin, tetrahydrobiopterin, or dihydrobiopterin.
    Type: Application
    Filed: August 5, 2020
    Publication date: September 1, 2022
    Inventors: Eleonora MEZZAROMA, Christopher RABENDER, Ross MIKKELSEN, Vasily YAKOVLEV, Neil SMITH